Stocklytics Platform
Asset logo for symbol DTIL
Precision BioSciences
DTIL73
$7.62arrow_drop_down1.03%-$0.08
High Growth
Asset logo for symbol DTIL
DTIL73

$7.62

arrow_drop_down1.03%

Performance History

Chart placeholder
Key Stats
Open$7.70
Prev. Close$7.70
EPS0.40
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$58.45M
LOWHIGH
Day Range7.47
7.95
52 Week Range7.47
19.43
Ratios
EPS0.40

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Precision BioSciences (DTIL)

Precision BioSciences Inc (DTIL) is a biotechnology company that focuses on developing gene editing and gene therapy solutions. The company's proprietary Arcus genome editing platform offers a versatile and precise way to modify genes, enabling the development of novel therapies for a variety of diseases. Precision BioSciences is committed to leveraging its technology to address unmet medical needs and improve patient outcomes.
One of the key factors to consider when evaluating Precision BioSciences Inc's stock is its historical price performance. Looking at the stock price history, we can see that DTIL has experienced fluctuations over the past year. The 52-week range for DTIL is [lowest price] to [highest price], indicating the volatility of the stock within that period. Investors should take note of this range and consider their risk tolerance when investing in DTIL.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Michael Amoroso
Headquarters
Durham
Employees
192
Exchange
NASDAQ
add Precision BioSciences  to watchlist

Keep an eye on Precision BioSciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Precision BioSciences 's (DTIL) price per share?

The current price per share for Precision BioSciences (DTIL) is $7.62. The stock has seen a price change of -$0.08 recently, indicating a -1.04% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Precision BioSciences (DTIL)?

For Precision BioSciences (DTIL), the 52-week high is $19.43, which is 154.99% from the current price. The 52-week low is $7.47, the current price is 2.01% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Precision BioSciences (DTIL) a growth stock?

Precision BioSciences (DTIL) has shown an average price growth of -6.65% over the past three years. It has received a score of 98 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Precision BioSciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Precision BioSciences (DTIL) stock price performance year to date (YTD)?

As of the latest data, Precision BioSciences (DTIL) has a year-to-date price change of -31.35%. Over the past month, the stock has experienced a price change of -13.31%. Over the last three months, the change has been -11.5%. Over the past six months, the figure is -36.97%. Looking at a longer horizon, the five-year price change stands at -97.9%.
help

Is Precision BioSciences (DTIL) a profitable company?

Precision BioSciences (DTIL) has a net income of -$61.32M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 83.06% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -3.69K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $48.73M, with a revenue growth rate of 94.15%, providing insight into the company's sales performance and growth. The gross profit is $40.47M. Operating income is noted at -$43.74M. Furthermore, the EBITDA is -$11.98M.
help

What is the market capitalization of Precision BioSciences (DTIL)?

Precision BioSciences (DTIL) has a market capitalization of $58.45M. The average daily trading volume is 7.62, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level